Essential Criteria BioPharmaceutical Investors Seek When Evaluating Compounds and Companies  

  • 81% of projects in the global biopharmaceutical pipeline are owned by small-to mid-sized companies
  • Success often depends on outside investment in out-license, acquisition, or commercialization agreements
  • Fully integrated pharmaceutical companies, as well as venture capitalists, look for specific attributes when evaluating investment opportunities
 

GET THE WHITEPAPER

Field will not be visible to web visitor

Copyright 2019 Industry Dive